FEROZ 1QFY27 profit jumps 23%

October 29, 2026 (MLN): Ferozsons Laboratories Limited (PSX: FEROZ) reported a 23% increase in its condensed interim consolidated net profit for the first quarter ended September 30, 2026 (1QFY27 / 3MFY27), reaching Rs395.77m compared to Rs321.95m in the corresponding period of the previous fiscal year.

Reflecting this bottom-line growth, basic and diluted earnings per share (EPS) for the three-month period rose 24% to Rs7.40, up from Rs5.95 in 3MFY26.

The primary catalyst driving performance was a 19% expansion in top-line net revenue, which reached Rs7.07bn compared to Rs5.94bn in 3MFY26.

Cost of sales increased 15% to Rs3.83bn from Rs3.33bn, allowing gross profit to surge 24% to Rs3.24bn against Rs2.61bn in the comparative quarter.

Consequently, the company's gross profit margin expanded to 45.85% from 43.94% in 3MFY26.

On the operational side, overheads expanded as selling and distribution expenses rose 27% to Rs2.12bn (up from Rs1.68bn), administrative expenses grew 16% to Rs332.65m, and other expenses stood at Rs66.60m.

Despite a 50% drop in other income to Rs26.07m (down from Rs51.70m), profit from operations expanded 16% to Rs748.05m compared to Rs643.20m recorded in the prior-year period.

Below the operating line, finance costs rose 6% to Rs110.64m compared to Rs104.69m in 3MFY26.

Minimum tax increased 63% to Rs12.58m from Rs7.71m, bringing profit before income tax up 18% to Rs624.83m.

Following an income tax expense of Rs229.06m (up 10% from Rs208.85m), Ferozsons Laboratories Limited securely closed the first quarter with a consolidated net profit of Rs395.77m.

Copyright Mettis Link News